Coronavirus vaccine breakthrough: Pfizer trial with 95% success – authorisation in days
In a major breakthrough in the race to find a solution to the pandemic, Pfizer has said its final results suggest its vaccine is 95 percent effective – up from its provisional 90 percent efficiency announced last week. The company, that works in partnership with BioNTech, said the final results from its latest trial mean it has reached the required two-months of safety data.
